Yoshito Zamami

11PUBLICATIONS
55CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursClinical pharmacy and pharmacy practiceMolecular targetsSocial epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 09, 2026
Incidence and impact of odontogenic infection-related febrile episodes during perioperative doxorubicin-cyclophosphamide or docetaxel-cyclophosphamide chemotherapy for breast cancer.

|May 18, 2026
Incidence of B-cell Malignancies in Patients with Lung Cancer Receiving PD-1 Blockade Therapy.

|Mar 03, 2026
Prescription Support Practice for Pharmacy Students: Pre-Post Educational Intervention Study.

Fuka Aizawa, Kenta Yagi, Tsukasa Higashionna

|Aug 18, 2025
Cardiotoxicity Assessment of EGFR Tyrosine Kinase Inhibitors Using Human iPS Cell-Derived Cardiomyocytes and FDA Adverse Events Reporting System.

Shota Yanagida, Hiroyuki Kawagishi, Mitsuo Saito

|Dec 24, 2024
Authors' Reply to Noguchi et al. Comment on: "Differences in the Adverse Event Profiles of Sodium-Glucose Cotransporter 2 Inhibitors Used in Patients with Diabetes and Heart Failure: An Analysis Using the Japanese Adverse Drug Event Report Database".

Toshiaki Sakamoto, Hirotaka Miyamoto, Junya Hashizume

|Apr 07, 2021
Population-Based Observational Study of Adverse Drug Event-Related Mortality in the Super-Aged Society of Japan.

Tomoko Funahashi, Toshihiro Koyama, Hideharu Hagiya

Pageof 2

Frequent Collaborators

4 joint publications

Yuki Izawa-Ishizawa

4 joint publications

Hirofumi Hamano

3 joint publications

Toshihiro Koyama

2 joint publications

Yasumasa Ikeda